Multiple sclerosis in 2020
Recent developments in the management of multiple sclerosis (MS) are ushering in a new era in MS treatment. The novel therapeutic disease-modifying agents that have been recently approved for the treatment of MS are B-cell therapies and various sphingosine-1-phosphate inhibitors. The Bruton's t...
Saved in:
| Main Authors: | Anshu Rohatgi, Neha Pandita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publications
2021-01-01
|
| Series: | Apollo Medicine |
| Subjects: | |
| Online Access: | http://www.apollomedicine.org/article.asp?issn=0976-0016;year=2021;volume=18;issue=3;spage=196;epage=199;aulast=Rohatgi |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01) -
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series
by: Alice Mariottini, et al.
Published: (2024-11-01) -
New autoimmune disorder development after immune reconstitution therapy for multiple sclerosis
by: Nataša Giedraitienė, et al.
Published: (2024-12-01) -
Analysis of early efficacy and immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma
by: Kaili Chen, et al.
Published: (2025-01-01) -
Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients
by: Jaimie Cohen, et al.
Published: (2024-11-01)